Advertisement

The trial, called Partnership for Aids Vaccine Evaluation (Pave), was to be conducted by a consortium of US agencies and private organisations. It was to have begun enlisting 8 500 volunteers last October to evaluate a vaccine developed by the National Institute of Allergy and Infectious Diseases.

The trial was shelved, however, after a similar vaccine developed by Merck & Co. failed to prevent the infection and lower blood levels of HIV among people who had already acquired the AIDS-causing virus, the newspaper said.

Data from the Merck vaccine trial also suggested that the shot might have increased some users' risk of acquiring an HIV infection.

Attempts to create an effective HIV/Aids vaccine have been in the making for more than 25 years, and developing one still appears years away, scientists told the Times. – (HealthDay News, July 2008)

Read more:
Aids vaccine decades away

 

Print this article on

Rate this article Poor 1 2 3 4 5 Excellent

JOBS

Senior Secretary Gauteng - North/Sandton Infrastructure Resource Gauteng - Johannesburg Management Accountant R450,000-500,000 Per Annum Cost To Company Gauteng - Johannesburg Financial Manager R350,000-400,000 Per Annum Cost To Company Gauteng - Johannesburg Financial and Project Accountant R300,000-360,000 Per Annum Cost To Company Gauteng - Johannesburg Financial Accountant R380,000-420,000 Per Annum Cost To Company Gauteng - Johannesburg SSIS Business Intelligence Specialists (SSIS; SSAS) R350,000-500,000 Per Annum Cost To Company Gauteng - North/Sandton Financial Accountant R350,000-450,000 Per Annum Cost To Company Gauteng - South Find more jobs Register your CV Post a job